14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:APRI
Delisted

Apricus Biosciences Fund Predictions

$1.03
+0 (+0%)
At Close: May 27, 2022
Currently predicting for Wed, 8 May 2024

APRI Predictions History

6 years ago
JuanC Villegas predicted that APRI for 2018-01-16 is going $2.55 (-6.93%)

6 years ago
JS predicted that APRI for 2018-01-16 is going $2.34 (-14.45%)

6 years ago
JoeStockTrader predicted that APRI for 2018-01-16 is going $2.41 (-11.90%)

Rank:

6 years ago
JS predicted that APRI for 2018-01-12 is going $2.36 (-13.72%)

6 years ago
bbullish2 predicted that APRI for 2018-01-12 is going $2.34 (-2.90%)

6 years ago
JS predicted that APRI for 2018-01-05 is going $2.05 (-11.26%)

6 years ago
Balagurubaran predicted that APRI for 2018-01-05 is going $2.10 (-0.47%)

Rank:

6 years ago
JS predicted that APRI for 2017-11-17 is going $1.61 (0.63%)

6 years ago
Austin predicted that APRI for 2017-08-02 is going $1.67 (25.56%)

Rank:

6 years ago
my.duyen.10130 predicted that APRI for 2017-08-02 is going $1.49 (4.20%)

Rank:
Click to get the best stock tips daily for free!

About Apricus Biosciences

Apricus Biosciences, Inc., a biopharmaceutical company, focuses on the development and commercialization of products and product candidates in the areas of urology and rheumatology. Its lead product is Vitaros, a topically-applied cream formulation of alprostadil used for the treatment of erectile dysfunction. The company’s marketing partners for Vitaros include Laboratoires Majorelle, Bracco S.p.A., Hexal AG (Sandoz), Takeda Pharmaceuticals Int... APRI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT